Literature DB >> 1863999

Defects in proliferative responses of T cells from patients with common variable immunodeficiency on direct activation of protein kinase C.

M E North1, A D Webster, J Farrant.   

Abstract

DNA synthesis in response to mitogens has been studied in T cells from nine patients with common variable immunodeficiency (CVI) and seven normal individuals. Five out of the nine patients had cells with subnormal responses to the mitogen phytohaemagglutinin (PHA). As PHA-induced responses are largely mediated through activation of Ca(2+)-dependent protein kinase C, we studied whether the defective response was still present on direct activation of protein kinase C. This was done using combinations of concentrations of phorbol 12,13,-dibutyrate and the calcium ionophore ionomycin which induced proliferation in normal T cells. We found that in CVI patients with T cells which had normal responses to PHA, responses to phorbol ester and ionomycin were at the same level as in normal T cells. However, with this treatment, in which the linkage between the membrane receptor and protein kinase C is bypassed, the level of DNA synthesis was still depressed in the patient group whose T cells had subnormal responses to PHA. IL-2 failed to restore the DNA synthesis to normal levels when added with the phorbol ester and ionomycin to T cells from one patient in this group. These data suggest that in a group of CVI patients there are defects in T cell activation pathways at or down-stream of protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1863999      PMCID: PMC1535737          DOI: 10.1111/j.1365-2249.1991.tb05704.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

Review 1.  Kinases and phosphatases in T-cell activation.

Authors:  D R Alexander; D A Cantrell
Journal:  Immunol Today       Date:  1989-06

2.  Clinical and immunologic analyses of 103 patients with common variable immunodeficiency.

Authors:  C Cunningham-Rundles
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

3.  IL-2 regulation of tyrosine kinase activity is mediated through the p70-75 beta-subunit of the IL-2 receptor.

Authors:  D K Ferris; J Willette-Brown; J R Ortaldo; W L Farrar
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

4.  Relationship between IL 2 synthesis and the proliferative response to PHA in different primary immunodeficiencies.

Authors:  M López-Botet; G Fontán; M C Garcia Rodriguez; M O de Landázuri
Journal:  J Immunol       Date:  1982-02       Impact factor: 5.422

5.  T-cell activation defect in common variable immunodeficiency: restoration by phorbol myristate acetate (PMA) or allogeneic macrophages.

Authors:  W Fiedler; K W Sykora; K Welte; J E Kolitz; C Cunningham-Rundles; K Holloway; G A Miller; L Souza; R Mertelsmann
Journal:  Clin Immunol Immunopathol       Date:  1987-08

6.  Requirements for the simultaneous presence of phorbol esters and calcium ionophores in the expression of human T lymphocyte proliferation-related genes.

Authors:  N Kumagai; S H Benedict; G B Mills; E W Gelfand
Journal:  J Immunol       Date:  1987-09-01       Impact factor: 5.422

7.  Defective DNA synthesis by T cells in acquired 'common-variable' hypogammaglobulinaemia on stimulation with mitogens.

Authors:  M E North; G P Spickett; J Allsop; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1989-04       Impact factor: 4.330

8.  Protein kinase C is required for responses to T cell receptor ligands but not to interleukin-2 in T cells.

Authors:  V E Valge; J G Wong; B M Datlof; A J Sinskey; A Rao
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

9.  Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens.

Authors:  G Pastorelli; M G Roncarolo; J L Touraine; G Peronne; P A Tovo; J E de Vries
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

10.  Comparison of phorbol ester/calcium ionophore and phytohemagglutinin-induced signaling in human T lymphocytes. Demonstration of interleukin 2-independent transferrin receptor gene expression.

Authors:  N Kumagai; S H Benedict; G B Mills; E W Gelfand
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

View more
  15 in total

1.  Characterization of immunologic defects in patients with common variable immunodeficiency (CVID) with intestinal disease.

Authors:  Shradha Agarwal; Paul Smereka; Noam Harpaz; Charlotte Cunningham-Rundles; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2011-01       Impact factor: 5.325

2.  Co-stimulation with anti-CD28 (Kolt-2) enhances DNA synthesis by defective T cells in common variable immunodeficiency.

Authors:  M E North; A N Akbar; N Borthwick; K Sagawa; M Funauchi; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1994-02       Impact factor: 4.330

3.  Failure in antigen responses by T cells from patients with common variable immunodeficiency (CVID).

Authors:  A J Stagg; M Funauchi; S C Knight; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1994-04       Impact factor: 4.330

4.  T cell phenotypes in patients with common variable immunodeficiency disorders: associations with clinical phenotypes in comparison with other groups with recurrent infections.

Authors:  E A L Bateman; L Ayers; R Sadler; M Lucas; C Roberts; A Woods; K Packwood; J Burden; D Harrison; N Kaenzig; M Lee; H M Chapel; B L Ferry
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

5.  Effect of 12,13-phorbol dibutyrate and ionomycin on defective B cells in common variable immunodeficiency.

Authors:  A Franz; A Bryant; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

6.  Impaired up-regulation of CD70 and CD86 in naive (CD27-) B cells from patients with common variable immunodeficiency (CVID).

Authors:  C Groth; R Drager; K Warnatz; G Wolff-Vorbeck; S Schmidt; H Eibel; M Schlesier; H-H Peter
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

7.  Autoimmune manifestations in common variable immunodeficiency.

Authors:  Stavroula Giannouli; Dimitra Anagnostou; Fotini Soliotis; Michalis Voulgarelis
Journal:  Clin Rheumatol       Date:  2004-06-18       Impact factor: 2.980

Review 8.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

9.  A double-blind, placebo-controlled, crossover therapy study with natural human IL-2 (nhuIL-2) in combination with regular intravenous gammaglobulin (IVIG) infusions in 10 patients with common variable immunodeficiency (CVID).

Authors:  J A Rump; A Jahreis; M Schlesier; S Stecher; H H Peter
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

10.  Defective integration of activating signals derived from the T cell receptor (TCR) and costimulatory molecules in both CD4+ and CD8+ T lymphocytes of common variable immunodeficiency (CVID) patients.

Authors:  V Thon; H M Wolf; M Sasgary; J Litzman; A Samstag; I Hauber; J Lokaj; M M Eibl
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.